Trial Profile
Expanded Access Protocol Using HBOC-201
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 22 Oct 2020
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Anaemia
- Focus Expanded access; Therapeutic Use
- 22 May 2017 Status changed from suspended to recruiting.
- 18 Oct 2016 New trial record